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Abstract
DNA methylation-based biomarkers of aging are highly correlated with actual age. Departures of methylation-estimated age
from actual age can be used to define epigenetic measures of child development or age acceleration (AA) in adults. Very little is
known about genetic or environmental determinants of these epigenetic measures of aging. We obtained DNA methylation
profiles using Infinium HumanMethylation450 BeadChips across five time-points in 1018 mother–child pairs from the Avon
Longitudinal Study of Parents and Children. Using the Horvath age estimation method, we calculated epigenetic age for these
samples. AAwas defined as the residuals from regressing epigenetic age on actual age. AAwas tested for associations with
cross-sectional clinical variables in children. We identified associations between AA and sex, birth weight, birth by caesarean
section and several maternal characteristics in pregnancy, namely smoking, weight, BMI, selenium and cholesterol level.
Offspring of non-drinkers had higher AA on average but this difference appeared to resolve during childhood. The associations
between sex, birth weight and AA found in ARIES were replicated in an independent cohort (GOYA). In children, epigenetic AA
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measures are associatedwith several clinically relevant variables, and early life exposures appear to be associatedwith changes
in AA during adolescence. Further research into epigenetic aging, including the use of causal inference methods, is required to
better our understanding of aging.
Introduction
There has been considerable recent interest in epigenetic bio-
markers of aging (1–6), which use an individual’s DNA methyla-
tion data to estimate their ‘epigenetic age’, a concept that could
be considered a form of biological age. The Horvath age estima-
tion method (1) had a correlation of 0.96 between actual and epi-
genetic age, with individual estimates of epigenetic age within 3
years of actual age, on average. Epigenetic age has the potential to
assess our biological age, but little is knownabout its relationship
with our basic physiology. Moreover, several recent papers have
found that the difference between epigenetic and actual age
(known as age acceleration, denoted AA) has biological signifi-
cance. A positive AA indicates an individual is ahead of their epi-
genetic clock, a negative AA (i.e. age deceleration) suggests an
individual is behind their epigenetic clock. For example, AA has
been found to be associated with obesity (7), Down’s syndrome
(8), HIV (9), physical and cognitive fitness (10) and all-cause mor-
tality in older individuals (11). Furthermore, the epigenetic clock
method has been applied to study aging in blood samples from
subjects with a severe developmental disorder (12) and to esti-
mate the ages of tissues from centenarians (13). However, there
has been no investigation on prenatal and antenatal factors
that affect AA in children. It is possible that the detrimental
consequences of a higher AA may accrue over time, initiating
in childhood. Conversely, it could be postulated that having a
positive AA during early life and childhood is developmentally
advantageous. To reflect this, we could refer to AA as an epigen-
etic measure of development in children, though for the sake of
clarity, we will use AA throughout this article.
The Horvath age estimation method was developed using a
training dataset of roughly 4000 samples from 20 healthy tissues
and cell types (1). These datasets were assembled using a com-
bination of Illumina HumanMethylation27 BeadChip (27K) and
Illumina HumanMethylation450 BeadChip (450K) technology.
The Horvath method uses 353 CpG sites which are common to
both the 27 and 450K platforms to estimate age. A noteworthy ad-
vantage of this age estimationmethod is its applicability to most
human tissues, cell types, and fluids (including blood). Freely
available software that implements themethod can be found on-
line (http://labs.genetics.ucla.edu/horvath/htdocs/dnamage) (1).
The Hannum age estimation method (2) was developed based
on a single dataset (n = 656) of Illumina 450K methylation values
taken from adult whole blood. It uses 71 CpG sites to estimate
age. Although both of these age estimationmethods have an un-
precedented accuracy in whole blood, relatively little is known
about exposures that affect epigenetic age.
The Accessible Resource for Integrated Epigenomic Studies
(ARIES) (14) project has generated Illumina Infinium 450K array
data from peripheral blood collected from 1018 women during
pregnancy (antenatal) and again 17 years later (follow-up). Epi-
genetic data were generated from 1018 children of the aforemen-
tioned women from cord blood and peripheral blood drawn
during both childhood (age 7) and adolescence (ages 15–17). We
applied both the Horvath and Hannum methods to estimate
the epigenetic age for each of these five time-points in ARIES.
In this article, we provide a comprehensive investigation
of AA in children using data from three stages of early life
(birth, 7 and 17). We also use linear mixed models to assess the
associations between pre-birth exposures with average AA and
changes in AA during childhood. We perform genetic analysis
of epigenetic age, involving the application of a whole-genome
restricted maximum likelihood (GREML) analysis for estimating
the proportion of variation in AA that is attributable to all com-
mon genetic variants (referred to as SNP heritability).
Results
There were 1018 different families in the ARIES sample, though
only 914 (cord), 973 (childhood), 974 (adolescence), 951 (ante-
natal) and 970 (follow-up) had required methylation data avail-
able at their respective clinic to estimate epigenetic age.
Sample characteristics are provided in Table 1. The GOYA study
was used for replication of findings and includes DNA methyla-
tion from 981 newborns, along with clinical information on
both mothers and children.
Replication of the accuracy of the epigenetic clock
Taking a random sample of 1018 children and mothers from
ARIES, there were correlations of 0.97 (Horvath) and 0.94 (Han-
num) between epigenetic age and actual age, with an average ab-
solute difference of 2.8 years (Horvath) and 16.8 years (Hannum)
between epigenetic and actual ages. Apart from the mean abso-
lute difference for the Hannum derived age estimate, our results
replicate the original findings (Table 2, Fig. 1). The Bland–Altman
plot in Figure 2 shows the disparity between the Horvath and
Hannum methods, particularly in children, this is likely due to
the fact that the Hannum method was developed using data
fromadults only. Furthermore, the correlation between epigenetic
age estimated at birth and gestational age at delivery was small
(Horvath r = 0.0033, Hannum r = 0.064).
Cross-sectional analysis
When considering the relationship between epigenetic age and
phenotypic traits in the ARIES children (Table 3), the strongest
association was between maternal levels of selenium during
pregnancy and offspring AA at age 7 (r =−0.140; P = 0.009) and at
birth (r =−0.103, P = 0.061). Girls tended to have lower AA on aver-
age than boys, and this association strengthened over the life
course (Fig. 3) from age 7 (r =−0.055, P = 0.085) to age 17 (r = 0.082,
P = 0.01). Birth weight in kilogramswas positively associatedwith
AA at age 7 (r = 0.079, P = 0.014) but negatively associated by age 17
(r = −0.068, P = 0.035); birth weight broken into low, normal and
high categories (Fig. 4) was associated with AA at age 7 (F = 5.13,
P = 0.006), but not at birth (F = 0.06, P = 0.941) or age 17 (F = 0.70,
P = 0.496). Positive associations were identified between offspring
AA and systolic BP (r = 0.093, P = 0.009), maternal weight (r = 0.074,
P = 0.026), maternal BMI (r = 0.073, P = 0.029), maternal smoking
(r = 0.097, P = 0.004) and having been delivered following a caesar-
ean section (r = 0.067, P = 0.048). A negative associationwas found
between offspring AA and maternal cholesterol (r = −0.103,
P = 0.031).
Longitudinal analysis
Correlation of epigenetic age between ARIES time-points became
stronger as age increased; birth and childhood samples had the
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lowest correlation (r = 0.109, P = 0.0012), followed by birth and
adolescent samples (r = 0.174, P < 0.0005), while the strongest cor-
relation in the offspring was between childhood and adolescent
samples (r = 0.260, P < 0.0005). Correlation was even stronger in
the ARIES mother’s epigenetic age between the antenatal and
follow-up samples (r = 0.498, P < 0.0005).
In the longitudinal analysis of AA in the ARIES children
(Table 4), maternal alcohol consumption during pregnancy had
a negative association with average AA during childhood and
adolescence (children of drinkers had 1.3 years lower AA on
average, 95% CI −0.11, 2.7). However, this difference was resolved
over time, with the offspring of drinkers having increased growth
of AA during childhood and adolescence (0.19 years of AA per
year of life, 95% CI 0.064, 0.308). Therewere other associations be-
tween average AA in offspring andmaternal weight, height, BMI,
cadmium and cotinine. There was a positive association between
maternal smoking and changes inAAduring childhood, with chil-
dren of smokers having increased growth of AA (0.22 years of AA
per year of life, 95% CI 0.07, 0.36). There were other associations
between AA changes and sex, parity and maternal cadmium.
Replication in the GOYA study
Newborn girls had a 0.06 year lower average AA than boys in the
GOYA study (95% CI 0.03, 0.09 years, P < 0.0005), which replicates
our own finding in children and adolescents in ARIES. Birth
weight in kilograms was positively associated with newborn AA
in GOYA (0.04 years per kilogram of birth weight, 95% CI 0.02, 0.07
years, P = 0.002); however, there was little evidence that birth
weight broken into categories of low, normal and high was asso-
ciatedwith newborn AA (Fig. 4). In the cross-sectional GOYA ana-
lysis, therewas little evidence for associations betweenmaternal
alcohol consumption (offspring of drinkers had 0.011 years higher
AA on average, 95% CI −0.03, 0.05 years, P = 0.589) or maternal
smoking (offspring of smokers had 0.02 years lower AA on aver-
age, 95% CI −0.01, 0.04 years lower, P = 0.206) during pregnancy
and offspring AA at birth.
Table 1. Characteristics of the 1018 ARIES sample (continuous)
Group Variable Clinic Mean/N SD Min Max
Children Age (years) Childhood 7.49 0.15 7.10 9.08
Adolescence 17.14 1.01 14.69 19.33
Epigenetic age (years) Birth 0.26 0.63 −0.59 16.68
Childhood 8.25 2.42 2.50 24.80
Adolescence 17.20 4.34 3.77 31.65
Birth weight (g) Birth 3488.2 487.29 1485.00 5140.00
Gestational age (weeks) Birth 39.56 1.52 30.00 44.00
Height (cm) Childhood 126.02 5.20 109.20 147.30
Adolescence 172.37 9.15 146.70 203.00
BMI (kg/m2) Childhood 16.21 2.04 12.65 29.15
Adolescence 22.61 3.90 14.74 50.06
Sex Birth Boys 495 (48%)
Girls 527 (52%)
Mothers Age (years) Antenatal 29.16 4.39 16.00 42.00
Follow-up 47.38 4.45 34.52 60.00
Epigenetic age (years) Antenatal 30.17 6.72 0.33 53.77
Follow-up 44.66 6.86 4.47 68.08
Weight (kg) Antenatal 61.64 10.51 40.00 122.27
Height (cm) Antenatal 164.56 6.59 144.78 185.42
BMI (kg/m2) Antenatal 22.77 3.66 14.23 45.24
Follow-up 26.58 5.33 17.40 54.03
Smoking Antenatal No 882 (88%)
Yes 117 (12%)
Alcohol Antenatal No 432 (44%)
Yes 570 (56%)
Breast fed Antenatal No 150 (15%)
Yes 828 (85%)
Education Antenatal CSE 88 (9%)
Voc. 72 (7%)
O Level 342 (34%)
A level 294 (30%)
Degree 205 (20%)
BMI, body mass index; CSE, Certificate of Secondary Education; Voc., vocational.
Table 2. Performance of Horvath and Hannum predicted ages in the
ARIES sample
Correlation between predicted
and actual age
Pearson correlation coefficient
Horvath 0.97
Hannum 0.94
Difference between actual
and predicted age (years)
Mean SD Min Max
Horvath 2.79 3.07 0.01 33.67
Hannum 16.75 7.26 0.09 36.41
Regression of predicted age
on actual age
Coefficient s.e. R2
Horvath 0.96 0.01 0.93
Hannum 1.22 0.01 0.89
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Whole-genome GREML analysis
Standard errors were very large due to small sample size, but
there was a trend of increasing SNP heritability point estimates
for AA as participant age increases (Fig. 5). Combining mothers
and children to improve precision yields a similar pattern of in-
creasing point estimates with increasing age, with the oldest
age combination (15-year-old children andmiddle agedmothers)
giving an SNP heritability estimate of 0.37 (s.e. 0.25, P = 6.6 × 10−5)
for the familial component of AA (Fig. 6).
Discussion
Summary
Using repeated blood draws from a cohort of 1018 mothers and
children in the UK, we have provided a thorough investigation
of epigenetic age in children. We found associations between
AA and sex, birth weight, caesarean section delivery and several
maternal characteristics, namely smoking in pregnancy, weight,
BMI, selenium and cholesterol level. In further longitudinal ana-
lysis of the ARIES offspring, we observed an association between
maternal alcohol consumption and smoking during pregnancy
with changes in AA during development. Offspring of non-drin-
kers had higher AA on average at birth, but this appeared to
resolve during childhood. Offspring of smokers had higher AA
on average and this difference became larger during childhood
and adolescence. This finding is congruent with a recent longitu-
dinal study of DNAmethylation levels in 28 smoking-related CpG
sites in the ARIES children (15). Differences identified at birth in
offspring tended to persist at maternal smoking-related CpG
sites. Results on birth weight (16) and maternal BMI (17)-related
CpG sites are more consistent with the maternal alcohol finding,
i.e. a resolution of birth differences during early life. Using an in-
dependent cohort (the GOYA sub-study of the Danish National
Birth Cohort), we found similar associations between sex, birth
weight and AA in children.
The accuracy of the Horvath method suggests a wide range of
potential uses, including forensic applications which have begun
to be explored (6,18). In this paper, we have begun to investigate
how and why individuals differ from their epigenetic age, with
findings in the ARIES cohort related to BMI in adults. While
therewas no clear replication of this BMI-AA association in an in-
dependent cohort (the KORA cohort), themodelling of AA is in its
infancy, and studies have found this BMI-AA association in liver
tissue (7). The lack of correlation between AA and several clinical
variables may also indicate that AA reflects an ‘intrinsic’ aging
rate that is independent of various aging factors. The observation
that the estimated genetic component of AA increased in older
study participantsmay indicate that the AAmeasure ismore bio-
logically meaningful in adults rather than children, though alter-
natively it could be a reflection of a decreasing environmental
influence on DNA methylation patterns over time. This accords
with our finding of strengthening within subject correlation
over time, which suggests the period of rapid early life changes
in methylation affects epigenetic age during development to a
greater extent than adulthood changes inmethylation. Future re-
search is needed to understand why the correlation of epigenetic
age increases as age increases. This may be due to the rapid
change ofmethylation in children comparedwith adults. Indeed,
the epigenetic clock has been found to be more accurate in chil-
dren, the younger the subjects, the more accurate the epigenetic
age (1,12).
Our heritability estimates suffered from a lack of power, but
were consistent with previous findings (11). The heritability esti-
mate fromour study (h = 0.37) is lower than that reportedHorvath
(1) (h = 1.0), which was based on a small number of cord blood
samples from twin pairs. Both of these heritability estimates
were based on relatively few samples. Future large scale studies
Figure 1. Horvath (left) and Hannum (right) predicted ages against actual ages from a random sample of 1018 individuals from the ARIES study.
Figure 2. Bland–Altman plot of Horvath predicted age minus Hannum predicted
age.
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Table 3. Correlation analysis and ANOVA of AA for ARIES children
Clinical variablesa Clinic for AA Correlation (or F-statistic*) P-value
Sex (M = 0, F = 1) Birth −0.019 0.565
Childhood −0.055 0.085
Adolescence −0.082 0.010
Parity Birth −0.018 0.596
Childhood 0.017 0.600
Adolescence −0.071 0.030
Caesarean (N = 0, Y = 1) Birth 0.067 0.048
Childhood 0.006 0.846
Adolescence 0.019 0.555
Birth weight (kg) Birth 0.011 0.734
Childhood 0.079 0.014
Adolescence −0.068 0.035
Birth weight (category)b Birth 0.01 0.988
Childhood 2.40 0.092
Adolescence 3.73 0.024
Gestational age at delivery (week) Birth 0.003 0.922
Childhood 0.029 0.363
adolescence −0.048 0.134
Breast feeding (N = 0, Y = 1) Birth 0.035 0.301
Childhood −0.010 0.756
Adolescence 0.026 0.434
Maternal alcohol (N = 0, Y = 1) Birth 0.034 0.307
Childhood −0.011 0.732
Adolescence −0.015 0.647
Maternal smoking (N = 0, Y = 1) Birth 0.097 0.004
Childhood 0.021 0.518
dolescence −0.016 0.616
Maternal educationb,c Birth 0.55 0.699
Childhood 0.37 0.831
Adolescence 1.40 0.232
Maternal weight (kg) Birth 0.002 0.948
Childhood 0.074 0.026
Adolescence 0.006 0.855
Maternal height (cm) Birth 0.004 0.907
Childhood −0.010 0.769
Adolescence −0.012 0.719
Maternal BMI (kg/m2) Birth 0.003 0.925
Childhood 0.073 0.029
Adolescence 0.005 0.877
Maternal cholesterol (mmol/l) Birth −0.043 0.384
Childhood −0.103 0.031
Adolescence 0.016 0.737
Maternal cadmium (µg/l) Birth −0.120 0.067
Childhood 0.034 0.592
Adolescence 0.051 0.418
Maternal lead (µg/l) Birth −0.037 0.499
Childhood −0.002 0.971
Adolescence −0.072 0.180
Maternal selenium (µg/l) Birth −0.103 0.060
Childhood −0.137 0.009
Adolescence 0.011 0.837
Maternal mercury (µg/l) Birth −0.030 0.601
Childhood −0.023 0.673
Adolescence −0.006 0.920
Maternal vitamin D (nmol/l) Birth −0.052 0.200
Childhood −0.002 0.950
Adolescence −0.009 0.823
Maternal cotinine (ng/ml) Birth −0.022 0.675
Childhood 0.059 0.238
Adolescence −0.019 0.707
Maternal age (years) Birth −0.027 0.427
Childhood 0.028 0.388
Adolescence −0.045 0.165
Table continues
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will be needed to arrive at precise estimates of the heritability of
AA in newborns andminors. While our heritability estimatemay
seem low, empirical evidence (19) has suggested that fitness re-
lated traits tend to have lower heritability than morphological
traits because selection acts to purify deleterious genetic vari-
ation, and one might consider age accelerated residuals in the
former category.
Strengths
The ARIES data include five time-points at which DNA methyla-
tion was measured in the same families and is a unique epigen-
etic resource. This allowed us to replicate the Horvath epigenetic
clock finding in a longitudinal cohort. Furthermore, ARIES is a
subsample within Avon Longitudinal Study of Parents and Chil-
dren (ALSPAC), which has measured thousands of variables
over many years. Thus, we were able to investigate the relation-
ship between AA and a wide range of clinically relevant factors,
as well asmodel changes in AA over time. Epigenetic age showed
substantial inter-individual correlation over time,with a stronger
correlation in the mothers than in their offspring. Among the
children, the inter-individual correlation strengthened with ac-
tual age.We replicated ourfinding that boys and thosewith larger
birth weight have higher AA in childhood in an independent
study (GOYA).
Limitations
Our findings are limited to DNA extracted from peripheral blood
(or cord blood in infants) so future research should evaluate
whether these variables relate to AA measures in other tissues
or cell types. For example, Horvath et al. (7) showed that BMI is
strongly correlated with AA in liver, but much less so in other tis-
sues such as adipose, muscle, or blood. Although the 1018
mother–child pairs are an excellent resource, we still have low
power to run heritability (GREML) analyses. These approaches
generally need several thousand samples in order to account
for multiple testing. AAs were adjusted for estimated cell-type
proportions; however, since these were estimated from the
DNA methylation data rather than actually measured, it is un-
clear whether incomplete adjustment has affected our findings.
Indeed, Marioni (11) finds that the AA measure estimated by
theHannummethod is significantly correlatedwith severalmea-
sures of cell counts (e.g. the abundance of senescent CD8 T cells
and naive CD8 T cells). The Horvath-based AA measure is less
confounded by the relative abundance of blood cell types,
which probably reflects that it was formulated frommultiple dif-
ferent tissues and cell types.Wewere unable to replicate our find-
ings on maternal smoking or alcohol consumption on offspring
AA, perhaps due to the fact that the replication cohort was
cross-sectional, as opposed to our longitudinal design. Assessing
the causal relationship between exposures and AA (through
Mendelian randomization, e.g. 20,21) is underpowered in our cur-
rent data. For example, we have an estimated 6% power to detect
a causal link between maternal smoking and offspring AA (see
Supplementary Material).
Table 3. Continued
Clinical variablesa Clinic for AA Correlation (or F-statistic*) P-value
Height (cm; measured at 7)d Childhood 0.061 0.058
Adolescence 0.058 0.073
BMI (kg/m2; measured at 7) Childhood 0.037 0.249
Adolescence 0.005 0.880
Cotinine (ng/ml; measured at 7) Childhood 0.071 0.031
Adolescence 0.033 0.313
Leptin (ng/ml; measured at 9) Adolescence 0.024 0.523
Interleukin 6 (pg/ml; measured at 9) Adolescence 0.068 0.065
Height (cm; measured at 17) Adolescence 0.051 0.144
BMI (kg/m2; measured at 17) Adolescence 0.017 0.620
Total cholesterol (mmol/l; measured at 17) Adolescence −0.030 0.433
HDL cholesterol (mmol/l; measured at 17) Adolescence 0.030 0.425
Triglycerides (mmol/l; measured at 17) Adolescence −0.010 0.794
LDL cholesterol (mmol/l; measured at 17) Adolescence −0.014 0.717
C-reactive protein (mg/l; measured at 15) Adolescence 0.004 0.905
Systolic BP (mmHg; measured at 17) Adolescence 0.093 0.009
Diastolic BP (mmHg; measured at 17) Adolescence −0.055 0.122
aMeasured at birth/in pregnancy unless otherwise stated.
bOne-way ANOVA F-statistic and associated P-value reported for ordinal variables.
cMaternal education is ordinal: CSE, vocational, O level, A level, degree.
dAssociation analysis only performed against AA measured at same time or before clinical variable.
Figure 3. AA differences by sex over the life course.
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Conclusions
Using serially collected DNA methylation, we have provided evi-
dence that epigenetic AA measures are associated with several
clinically relevant variables in both mothers and children. We
have found and replicated strong associations between prenatal
and early life factors and epigenetic age in children. Further re-
search [including the use of causal inference methods such as
Mendelian randomization (20,21)] and replication are needed to
understand the key drivers behind our epigenetic clock and its
relation to development and aging.
Materials and Methods
Study population
This study used DNAmethylation data generated under the aus-
pices of the ALSPAC (22,23). ALSPAC recruited 14 541 pregnant
women with expected delivery dates between April 1991 and
December 1992. Of these initial pregnancies, there were 14 062
live births and 13 988 children who were alive at 1 year of age.
The study website contains details of all the data that are avail-
able through a fully searchable data dictionary (http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary).
As part of theARIES (14) project (http://www.ariesepigenomics.
org.uk), a subsample of 1018 ALSPAC child–mother pairs had DNA
methylationmeasured using the InfiniumHumanMethylation450
BeadChip (Illumina, Inc.) (24). In this study, we use DNAmethyla-
tion data generated from cord blood andperipheral blood samples
at age 7 and again at age 15 or 17 years, leading to three measure-
ments of DNAmethylation per child. DNAmethylation data were
also generated on the mothers of these children, from blood sam-
ples takenduringpregnancyandat a follow-up clinic 17 years later
using the same platform.
Laboratory methods, quality control and pre-processing
All DNA methylation wet-lab and pre-processing analyses were
performed at the University of Bristol as part of the ARIES project.
Following extraction, DNA was bisulfite converted using the
Zymo EZ DNA MethylationTM kit (Zymo, Irvine, CA, USA). Infi-
nium HumanMethylation450 BeadChips were used to measure
genome-wide DNA methylation levels at over 485 000 CpG sites.
The arrays were scanned using an Illumina iScan, with initial
quality review using GenomeStudio. The level of methylation is
expressed as a ‘beta’ value (β-value), ranging from 0 (no cytosine
methylation) to 1 (complete cytosine methylation). β-Values are
reported as percentages. Several quality control steps were in-
cluded in the laboratory pipeline which are described in detail
elsewhere (16).
Epigenetic age
Using the online epigenetic clock calculator (http://labs.genetics.
ucla.edu/horvath/dnamage/), we obtained DNAmethylation pre-
dicted age using both the Horvath (1) and Hannum (2) methods,
using raw β-values from the ARIES study. The Horvathmethod is
based on 353 CpG sites, while the Hannum prediction uses 71
sites. Along with predicted age, the online calculator estimates
Figure 4. Birth weight category and AA in GOYA newborns (top left), ARIES newborns (top right), ARIES children (bottom left) and ARIES adolescents (bottom right).
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cell-type proportions and calculates raw AA differences (pre-
dicted-actual age) and AA residuals (the residuals from a linear
regression of epigenetic age on actual age, which we call age ac-
celeration and denote AA). AA is uncorrelated with actual age
and contains information about the methylation age profiles of
each sample, i.e. a positive residual corresponds to an individual
whose methylation age is ahead of their actual age and vice
versa. The online calculator also provides AA adjusted for cell
heterogeneity, by way of estimated cell-type proportions.
Replication of previous findings
Using the ARIES data, we sought to replicate previous findings
which found a correlation of 0.96 [both Horvath (1) and Hannum
(2)] and an average difference of 2.9 years [Horvath (1)) or 3.9 years
(Hannum (2)] between predicted and actual age. To coincidewith
the spread of ages in the original work, we randomly selected a
sample of 1018 different individuals from across the five time-
points in ARIES and compared actual against DNA methylation
predicted age from each method.
Variables assessed
To investigate associations with AA, we assessed biological mea-
sures from the ARIES children and their mothers. For the chil-
dren, these were sex (coded boy 0, girl 1), birth weight [both
continuous and broken into low (<2.5 kg), normal and high
(>4 kg) categories to account for U-shaped trend between birth
weight and chronic disease risk (25)], gestational age at delivery,
parity and delivery method (natural/caesarean). We also tested
whether maternal characteristics during pregnancy were related
to offspring AA, including maternal age, height, weight, BMI,
alcohol consumption (Y/N), smoking status (Y/N) and highest
education level achieved; we also investigated offspring AA
against maternal levels of cholesterol, cadmium, lead, mercury,
selenium, cotinine and vitamin D during pregnancy. These re-
present 19 variables which could be associated with AA from
birth. We supplement these with further variables which could
be associated with AA at either the childhood (age 7) or adoles-
cent (ages 15–17) clinics: whether the child was breast fed (Y/
N), cotinine (at 7), leptin (at 9), interleukin-6 (at 9), C-reactive pro-
tein (at 15), cholesterol (total, LDL, HDL, triglycerides at 17) and
diastolic/systolic blood pressure (at 17).
For the ARIES mothers (results provided in Supplementary
Material), there were two time-points with DNA methylation
and clinical variables available. During pregnancy, we compared
AA against contemporaneousmeasures of height, BMI, smoking,
alcohol intake, education, socio-economic position (occupation)
and total cholesterol. At the mother’s follow-up clinic, we
included height, BMI, smoking, alcohol intake, education, socio-
economic position (occupation); systolic and diastolic blood pres-
sure; total, HDL and LDL cholesterol, triglyceride and C-reactive
protein levels.
Statistical analysis
All AAs were adjusted for estimated cell-type composition using
the online calculator. Pearson’s correlation, R2 and mean differ-
ence between predicted and actual age were used to assess the
performance of the age prediction methods. A Bland–Altman
plot was used to investigate the agreement of age predictions
from each method.
Pearson correlation tests were used to investigate the linear
relationship between Horvath AA and continuous or binary
Table 4. Longitudinal analysis of AA
Clinical variable Association with
average AA (years)
during childhood
and adolescence
95% CI P-value Associations with changes
in AA (AA years per year
of life) during childhood
and adolescence
95% CI P-value
Sex (M = 0,F = 1) −0.499 (−1.866,0.867) 0.47 −0.136 (−0.251, −0.02) 0.022
Caesarean (N = 0, Y = 1) −1.67 (−4.61,1.27) 0.27 0.201 (−0.03,0.433) 0.088
Parity 0.179 (−0.809,1.167) 0.72 −0.038 (−0.11,0.035) 0.308
Birth weight (kg) 0.0003 (−0.001,0.002) 0.72 −0.00004 (−0.00017,0.00009) 0.583
Gestational age (weeks) −0.027 (−0.674,0.621) 0.94 0.007 (−0.038,0.053) 0.752
Maternal age (years) −0.003 (−0.198,0.193) 0.98 0.001 (−0.013,0.015) 0.871
Maternal weight (kg) −0.892 (−1.686, −0.097) 0.03 0.004 (−0.002,0.01) 0.178
Maternal height (cm) 0.64 (0.038,1.242) 0.04 0.003 (−0.004,0.011) 0.366
Maternal BMI (kg/m2) 2.212 (0.036,4.387) 0.05 0.011 (−0.009,0.03) 0.285
Maternal smoking (N = 0, Y = 1) 1.822 (−1.271,4.915) 0.25 0.216 (0.073,0.36) 0.003
Maternal alcohol (N = 0, Y = 1) −1.297 (−2.705,0.11) 0.07 0.186 (0.064,0.308) 0.003
Maternal cholesterol (mmol/l) 0.257 (−0.301,0.815) 0.37 −0.016 (−0.06,0.028) 0.467
Maternal cadmium (µg/l) −1.616 (−3.25,0.018) 0.05 0.092 (0.014,0.171) 0.021
Maternal lead (µg/l) −0.078 (−0.578,0.421) 0.76 −0.02 (−0.061,0.021) 0.345
Maternal selenium (µg/l) 0.00027 (−0.021,0.022) 0.98 −0.001 (−0.003,0.001) 0.194
Maternal mercury (µg/l) 0.42 (−0.375,1.214) 0.30 −0.01 (−0.071,0.051) 0.749
Maternal vitamin D (nmol/l) −0.002 (−0.025,0.02) 0.83 0.00038 (−0.002,0.002) 0.714
Maternal cotinine (ng/ml) −0.001 (−0.001,0.000004) 0.05 0.00002 (−0.00002,0.00005) 0.408
Maternal education
CSE Reference 0.76 Reference 0.183
Voc. −0.304 (−1.841,1.234) 0.11 (−0.019,0.239)
O Level −0.238 (−1.556,1.081) 0.038 (−0.073,0.148)
A Level −0.38 (−1.694,0.933) 0.058 (−0.052,0.167)
Degree −0.507 (−1.865,0.85) 0.103 (−0.01,0.215)
BMI, body mass index; CSE, Certificate of Secondary Education; Voc., vocational.
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variables, one-way analysis of variance (ANOVA) was used to
compare Horvath AA across categories of maternal education
and birth weight category. In total, there were 78 (children) and
33 (mother) tests such yielding a Bonferroni correction P-value
threshold of 4.5 × 10−4 (0.05/111). We report the relationship be-
tween adult AA and clinical variables in SupplementaryMaterial,
as the focus of the paper is on AA in children.
Replication of findings in the ARIES children was carried out
using cord blood samples from the GOYA study (sample size
981, mean maternal age at pregnancy 29.2, range 18–44) (26,27)
which had phenotypic information available on mothers. The
GOYA study is a subsample of the Danish National Birth Cohort,
which took the most obese mothers from the DNBC along with
controls who were randomly sampled from the remaining
mothers in the DNBC. For analysis of the GOYA data, we present
results of linear regression of AA on phenotypes adjusted for
case–control status. Replication of findings in the ARIES mothers
was attempted in the women of the KORA cohort (sample size
921, mean age 60.6, range 39–81, further details provided in Sup-
plementary Material) (28).
Correlation between epigenetic ages at different clinics was
used to investigate the strength of association within subjects
over the life course. Mutually adjusted, linear mixed models
(29) were then used in the offspring data to investigate the effect
of the 19 early life exposures (described above) on average AA and
also AA changes during childhood and adolescence. With 19 ex-
posures, the Bonferroni corrected in this test P-value is 0.05/20 =
0.0263. This analysis was not repeated in themothers as early life
exposures were not present for them.
Whole-genome methods
This analysis attempted to estimate SNP heritability of AA using
GCTA software (30). For each time point ∼1.1 million Hapmap3
(31) SNPs (minor allele frequency > 0.01 and imputation info
>0.8) were used to construct a genetic relationship matrix and
SNP heritability (proportion of phenotypic variance explained
by all SNPs) was estimated for the AA phenotype, fitting sex
and 10 principle components as covariates. These tag SNPs
were used to reduce bias in the SNP heritability estimation that
can be incurred in the presence of very large levels linkage dis-
equilibrium. Any pairs of individuals with relatedness >0.05
were excluded from the analysis. In order to improve power, we
also attempted to estimate heritability by combining mothers
and children together. A likelihood ratio test was used to obtain
P-values using a χ2 test with 2 degrees of freedom. In order to es-
timate true heritability, the same procedure was followed except
all individuals who were not mother–child pairs had genetic re-
latedness set to 0 in the genetic relationship matrix. This pro-
vides an upper bound the heritability estimate as it is liable to
also include common environmental effects. Nevertheless, it is
an orthogonal approach to the GREML analysis.
Ethical Approval
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
Supplementary Material
Supplementary Material is available at HMG online.
Acknowledgements
We are extremely grateful to all the families who took part in this
study, the midwives for their help in recruiting them, and the
whole ALSPAC team, which includes interviewers, computer
and laboratory technicians, clerical workers, research scientists,
volunteers, managers, receptionists and nurses. The UK Medical
ResearchCouncil and theWellcomeTrust (Grant ref: 102215/2/13/
Figure 5. SNP heritability estimates for AA at each time point using unrelated
individuals. There is a larger genetic component when individuals increase in
age.
Figure 6.Heritability analysis of AA. The analysiswas performed for eachmother–
child time-point combination (this was done to improve power), showing a
general increase in genetic variance for AA as individuals get older. AN,
AnteNatal clinic; FOM, Follow-on Mother’s clinic.
Human Molecular Genetics, 2016, Vol. 25, No. 1 | 199
2) and the University of Bristol provide core support for ALSPAC.
This publication is the work of the authors and Andrew Simpkin
will serve as guarantors for the contents of this paper.
Conflict of Interests statement. None declared.
Funding
This research was specifically funded by UK Economic & Social
Research Council grant RES-060-23-0011, UK Medical Research
Council grants G0601625, G0600705 and MR/L011824/1, and Euro-
pean Research Council grant 269874. ARIES was funded by the
BBSRC (BBI025751/1 and BB/I025263/1). Core program support
for ALSPAC is provided by the Medical Research Council (MRC)
and the Wellcome Trust (Grant ref: 102215/2/13/1) and the Uni-
versity of Bristol. Supplementary funding to generate DNA
methylation data which is (or will be) included in ARIES has
been obtained from the MRC, ESRC, NIH and other sources.
ARIES is maintained under the auspices of the MRC Integrative
Epidemiology Unit at the University of Bristol (MC_UU_12013/2,
MC_UU_12013/8, MRC_UU_12013/9). DNA methylation was ob-
tained for the GOYA cohort using funding from the MRC IEU. The
KORAcohortwas supportedby theGermanFederalMinistryof Edu-
cation and Research (BMBF) within the framework of the e:Med
research and funding concept (grant number 01ZX1313A-2014).
Funding to pay the Open Access publication charges for this article
was provided by the University of Bristol - RCUKOpen Access fund.
References
1. Horvath, S. (2013) DNAmethylation age of human tissues and
cell types. Genome Biol., 14, R115.
2. Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G.,
Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y. et al.
(2013) Genome-wide methylation profiles reveal quantitative
views of human aging rates. Mol. Cell, 49, 359–367.
3. Bocklandt, S., Lin, W., Sehl, M.E., Sánchez, F.J., Sinsheimer,
J.S., Horvath, S. and Vilain, E. (2011) Epigenetic predictor of
age. PLoS ONE, 6, e14821.
4. Jones, M.J., Goodman, S.J. and Kobor, M.S. (2015) DNAmethy-
lation and healthy human aging. Aging Cell., doi:10.1111/
acel.12349.
5. Weidner, C.I., Lin, Q., Koch, C.M., Eisele, L., Beier, F., Ziegler, P.,
Bauerschlag, D.O., Jöckel, K.-H., Erbel, R., Mühleisen, T.W. et al.
(2014) Aging of blood can be tracked by DNA methylation
changes at just three CpG sites. Genome Biol., 15, R24.
6. Zbiec ́-Piekarska, R., Spólnicka, M., Kupiec, T., Makowska, _Z.,
Spas, A., Parys-Proszek, A., Kucharczyk, K., Płoski, R. and
Branicki, W. (2015) Examination of DNA methylation status
of the ELOVL2 marker may be useful for human age predic-
tion in forensic science. Foren. Sci. Int.-Gen., 14, 161–167.
7. Horvath, S., Erhart,W., Brosch, M., Ammerpohl, O., von Schön-
fels, W., Ahrens, M., Heits, N., Bell, J.T., Tsai, P.-C., Spector, T.D.
et al. (2014) Obesity accelerates epigenetic aging of human
liver. Proc. Natl. Acad. Sci. USA, 111, 15538–15543.
8. Horvath, S., Garagnani, P., Bacalini,M.G., Pirazzini, C., Salvioli,
S., Gentilini, D., Di Blasio, A.M., Giuliani, C., Tung, S., Vinters,
H.V. et al. (2015) Accelerated epigenetic aging in Down
syndrome. Aging Cell., 14, 491–495.
9. Horvath,S.andLevine,A.J. (2015)HIV-1infectionacceleratesage
according to the epigenetic clock. J. Infect. Dis., 212, 1563–1573.
10. Marioni, R.E., Shah, S., McRae, A.F., Ritchie, S.J., Muniz-Ter-
rera, G., Harris, S.E., Gibson, J., Redmond, P., Cox, S.R., Pattie,
A. et al. (2015) The epigenetic clock is correlated with physical
and cognitive fitness in the Lothian Birth Cohort 1936.
Int. J. Epidemiol., 44, 1388–1396.
11. Marioni, R.E., Shah, S., McRae, A.F., Chen, B.H., Colicino, E.,
Harris, S.E., Gibson, J., Henders, A.K., Redmond, P., Cox, S.R.
et al. (2015) DNA methylation age of blood predicts all-cause
mortality in later life. Genome Biol., 16, 25.
12. Walker, R.F., Liu, J.S., Peters, B.A., Ritz, B.R., Wu, T., Ophoff, R.
A. and Horvath, S. (2015) Epigenetic age analysis of children
who seem to evade aging. Aging, 7, 334–339.
13. Horvath, S., Mah, V., Lu, A.T., Woo, J.S., Choi, O.-W., Jasinska,
A.J., Riancho, J.A., Tung, S., Coles, N.S., Braun, J. et al. (2015)
The cerebellum ages slowly according to the epigenetic
clock. Aging (Milano), 7, 294–306.
14. Relton,C.L., Gaunt,T.,McArdle,W.,Ho,K.,Duggirala,A., Shihab,
H.,Woodward,G., Lyttleton, O., Evans, D.M., Reik,W. et al. (2015)
Data resource profile: Accessible Resource for Integrated Epige-
nomic Studies (ARIES). Int. J. Epidemiol., 44, 1181–1190.
15. Richmond, R.C., Simpkin, A.J., Woodward, G., Gaunt, T.R.,
Lyttleton, O., McArdle,W.L., Ring, S.M., Smith, A.D., Timpson,
N.J., Tilling, K. et al. (2014) Prenatal exposure to maternal
smoking and offspring DNA methylation across the life-
course: findings from the Avon Longitudinal Study of Parents
and Children (ALSPAC). Hum. Mol. Genet., 24, 2201–2217.
16. Simpkin, A.J., Suderman,M., Gaunt, T.R., Lyttleton, O., McArdle,
W.L., Ring, S.M., Tilling, K., Smith, G.D. and Relton, C.L. (2015)
Longitudinal analysis of DNA methylation associated
with birth weight and gestational age. Hum. Mol. Genet., 24,
3752–3763.
17. Sharp, G., Lawlor, D., Richmond, R., Fraser, A., Simpkin, A.,
Suderman, M., Shihab, H., Lyttleton, O., McArdle, W., Ring,
S. et al. (2015) Maternal pre-pregnancy BMI and gestational
weight gain, offspring DNA methylation and later offspring
adiposity: findings from the Avon Longitudinal Study of
Parents and Children. Int. J. Epidemiol., 44, 1288–1304.
18. Relton, C.L., Hartwig, F.P. and Smith, G.D. (2015) From stem
cells to the law courts: DNAmethylation, the forensic epigen-
ome and the possibility of a biosocial archive. Int. J. Epidemiol.,
44, 1083–1093.
19. Visscher, P.M., Hill, W.G. and Wray, N.R. (2008) Heritability in
the genomics era—concepts and misconceptions. Nat. Rev.
Genet., 9, 255–266.
20. Smith, G.D. and Ebrahim, S. (2003) ‘Mendelian randomization’:
can genetic epidemiology contribute to understanding envir-
onmental determinants of disease? Int. J. Epidemiol., 32, 1–22.
21. Relton, C.L. and Smith, G.D. (2012) Two-step epigenetic
Mendelian randomization: a strategy for establishing the
causal role of epigenetic processes in pathways to disease.
Int. J. Epidemiol., 41, 161–176.
22. Boyd, A., Golding, J., Macleod, J., Lawlor, D.A., Fraser, A.,
Henderson, J., Molloy, L., Ness, A., Ring, S. and Smith, G.D.
(2012) Cohort profile: the ‘children of the 90s’—the index
offspring of the Avon Longitudinal Study of Parents and
Children. Int. J. Epidemiol., 42, 111–127.
23. Fraser, A., Macdonald-Wallis, C., Tilling, K., Boyd, A., Golding,
J., Smith, G.D., Henderson, J., Macleod, J., Molloy, L., Ness, A.
et al. (2013) Cohort profile: theAvon Longitudinal Studyof Par-
ents and Children: ALSPAC mothers cohort. Int. J. Epidemiol.,
42, 97–110.
24. Dedeurwaerder, S., Defrance, M., Calonne, E., Denis, H.,
Sotiriou, C. and Fuks, F. (2011) Evaluation of the infinium
methylation 450K technology. Epigenomics, 3, 771–784.
25. Pettitt, D.J. and Jovanovic, L. (2001) Birth weight as a predictor
of type 2 diabetes mellitus: the U-shaped curve. Curr. Diab.
Rep., 1, 78–81.
200 | Human Molecular Genetics, 2016, Vol. 25, No. 1
26. Olsen, J., Melbye, M., Olsen, S.F., Sørensen, T.I., Aaby, P.,
Andersen, A.-M.N., Taxbøl, D., Hansen, K.D., Juhl, M., Schow,
T.B. et al. (2001) The Danish National Birth Cohort-its
background, structure and aim. Scand. J. Pub. Health, 29,
300–307.
27. Nohr, E.A., Timpson, N.J., Andersen, C.S., Davey Smith, G.,
Olsen, J. and Sørensen, T. (2009) Severe obesity in young
women and reproductive health: the Danish National Birth
Cohort. PLoS ONE, 4, e8444.
28. Holle, R., Happich, M., Löwel, H. and Wichmann, H. and
MONICA/KORA Study Group (2005) KORA – a research
platform for population based health research. Das Gesund-
heitswesen, 67, 19–25.
29. Laird, N.M. and Ware, J.H. (1982) Random-effects models for
longitudinal data. Biometrics, 38, 963–974.
30. Yang, J., Benyamin, B., McEvoy, B.P., Gordon, S., Henders, A.K.,
Nyholt, D.R.,Madden, P.A., Heath, A.C.,Martin,N.G.,Montgom-
ery, G.W. et al. (2010) Common SNPs explain a large proportion
of the heritability for human height. Nat. Genet., 42, 565–569.
31. Speed, D., Hemani, G., Johnson, M.R. and Balding, D.J. (2012)
Improved heritability estimation from genome-wide SNPs.
Am. J. Hum. Genet., 91, 1011–1021.
Human Molecular Genetics, 2016, Vol. 25, No. 1 | 201
